Journal of Renal Nutrition
Volume 20, Issue 2 , Pages 112-120 , March 2010

Effects of Chromium Histidinate on Renal Function, Oxidative Stress, and Heat-Shock Proteins in Fat-Fed and Streptozotocin-Treated Rats

  • Ayhan Dogukan, MD

      Affiliations

    • Department of Nephrology, School of Medicine, Firat University, Elazig, Turkey
    • ,
  • Mehmet Tuzcu, PhD

      Affiliations

    • Department of Biology, Faculty of Science, Firat University, Elazig, Turkey
    • ,
  • Vijaya Juturu, PhD

      Affiliations

    • Technical Services and Scientific Affairs, Nutrition 21, Inc., Purchase, New York
    • ,
  • Gurkan Cikim, MD

      Affiliations

    • Department of Biochemistry, Sarahatun Hospital, Elazig, Turkey
    • ,
  • İbrahim Ozercan, MD

      Affiliations

    • Department of Pathology, School of Medicine, Firat University, Elazig, Turkey
    • ,
  • James Komorowski, MSc

      Affiliations

    • Technical Services and Scientific Affairs, Nutrition 21, Inc., Purchase, New York
    • ,
  • Kazim Sahin, DVM, PhD

      Affiliations

    • Department of Animal Nutrition, Faculty of Veterinary Science, Firat University, Elazig, Turkey
    • Corresponding Author InformationAddress reprint requests to Kazim Sahin, DVM, PhD, Department of Animal Nutrition, Faculty of Veterinary Science, Firat University, 23119 Elazig, Turkey.

References 

  1. Barnard RJ, Roberts CK, Varon SM, Berger JJ. Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J Appl Physiol. 1998;84:1311–1315
  2. Buettner R, Schölmerich J, Bollheimer LC. High-fat diet: modeling the metabolic disorders of human obesity in rodents. Obesity. 2007;15:798–808
  3. Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus—a review. Diabetes Technol Ther. 2006;8:677–687
  4. Bartlett HE, Eperjesi F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthalmic Physiol Opt. 2008;28:503–523
  5. Praga M. Obesity: a neglected culprit in renal disease. Nephrol Dial Transplant. 2002;17:1157–1159
  6. Abrass CK. Overview: obesity—what does it have to do with kidney disease?. J Am Soc Nephrol. 2004;15:2768–2772
  7. Bagby SP. Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?. J Am Soc Nephrol. 2004;15:2775–2791
  8. El-Atat FA, Stas SN, McFarlane SI, et al. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol. 2004;15:2816–2827
  9. Kume S, Uzu T, Araki S, Sugimoto T, et al. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J Am Soc Nephrol. 2007;18:2715–2723
  10. Jiang T, Wang Z, Proctor G, et al. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem. 2005;280:32317–32325
  11. Wallach S. Clinical and biochemical aspects of chromium deficiency. J Am Coll Nutr. 1985;4:107–120
  12. Becker DJ, Reul B, Ozeelikay A, et al. Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeagenic enzymes in diabetic rats. Diabetologia. 1996;39:3–11
  13. Faure P, Roussel A, Coudray C, Richard MJ, Halimi S, Favier A. Zinc and insulin sensitivity. Biol Trace Elem Res. 1992;32:305–310
  14. Sahin K, Onderci M, Tuzcu M, et al. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metabolism. 2007;56:1233–1240
  15. Feng W, Ding W, Qian Q, et al. Comparison of the chromium distribution in organs and subcellular fractions of normal and diabetic rats by using enriched stable isotope Cr-50 tracer technique. Biol Trace Elem Res. 1999;71:121–129
  16. Ding W, Chai Z, Duan P, et al. Serum and urine chromium concentrations in elderly diabetics. Biol Trace Elem Res. 1998;63:231–237
  17. Cefalu WT, Wang ZQ, Zhang XH, et al. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr. 2002;132:1107–1114
  18. Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care. 2004;27:2741–2751
  19. Watanabe M, Suliman ME, Qureshi AR, et al. Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. Am J Clin Nutr. 2008;87:1860–1866
  20. Cefalu WT, Bell-Farrow AD, Stegner J, et al. Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exp Med. 1999;12:71–83
  21. Anderson RA, Polansky MM, Bryden NA. Chromium-histidine complexes as nutrient supplements. US patent issued. February 10, 2004;
  22. Anderson RA, Polansky MM, Bryden NA. Stability and absorption of chromium and absorption of chromium histidinate complexes by humans. Biol Trace Elem Res. 2004;101:211–218
  23. Anderson RA. Nutritional factors influencing the glucose/insulin system: chromium. J Am Coll Nutr. 1997;16:404–410
  24. Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr. 1998;17:548–555
  25. Reed MJ, Meszaros K, Entes LJ, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism. 2000;49:1390–1394
  26. Karatepe M. Simultaneous determination of ascorbic acid and free malondialdehyde in human serum by HPLC/UV. LC-GC North Am. 2004;22:362–365
  27. Wong YT, Ruan R, Tay FEH. Relationship between levels of oxidative DNA damage, lipid peroxidation and mitochondrial membrane potential in young and old F344 rats. Free Radic Res. 2006;40:393–402
  28. Association of Official Analytical Chemists: Official Methods of Analysis, 15th Ed. Arglinton, VA: Association of Official Analytical Chemists, 1990.
  29. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275
  30. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685
  31. Baydas G, Tuzcu M. Protective effects of melatonin against ethanol-induced reactive gliosis in hippocampus and cortex of young and aged rats. Exp Neurol. 2005;194:175–181
  32. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M, Hermann DM. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J. 2005;19:2026–2028
  33. Kilic E, Kilic U, Wang Y, Bassetti CL, Marti HH, Hermann DM. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J. 2006;20:1185–1187
  34. Ross MH, Reith EJ, Romrell LJ. Histology—A Text and Atlas. Baltimore: Williams and Wilkins; 1989;
  35. SAS Institute . Inc.: SAS User's Guide: Statistics. Cary, NC: SAS Institute, Inc.; 1999;
  36. Atalay M, Laaksonen DE, Niskanen L, et al. Altered antioxidant enzyme defenses in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress. Acta Physiol Scand. 1997;161:195–201
  37. Ceriello A, Bortolotti N, Falleti E, et al. Total radical trapping antioxidant parameter in NIDDM patients. Diabetes Care. 1997;20:194–197
  38. Atalay M, Laaksonen DE. Diabetes, oxidative stress and physical exercise. J Sports Sci Med. 2002;1:1–14
  39. Shinde UA, Goyal RK. Effect of chromium picolinate on histopathological alterations in STZ and neonatal STZ diabetic rats. J Cell Mol Med. 2003;7:322–329
  40. Mita Y, Ishihara K, Fukuchi Y, et al. Supplementation with chromium picolinate recovers renal Cr concentration and improves carbohydrate metabolism and renal function in type 2 diabetic mice. Biol Trace Elem Res. 2005;105:229–248
  41. Cupo MA, Donaldson WE. Chromium and vanadium effects on glucose metabolism and lipid synthesis in the chick. Poult Sci. 1987;66:120–126
  42. Lambert B, Jacquemin C. Inhibition by insulin of the adrenaline-stimulated adenylate cyclase in rat adipose tissue. FEBS Lett. 1979;105:19–22
  43. Shinde UA, Sharma G, Xu YJ, et al. Anti-diabetic activity and mechanism of action of chromium chloride. Exp Clin Endocrinol Diabetes. 2004;112:248–252
  44. Sun Y, Clodfelder BJ, Shute AA, et al. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3)) (6)(H(2)O)(3)](+) decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats. J Biol Inorg Chem. 2002;7:852–862
  45. Machalinski B, Walczak M, Syrenicz A, et al. Hypoglycemic potency of novel trivalent chromium in hyperglycemic insulin-deficient rats. J Trace Elem Med Biol. 2006;20:33–39
  46. Wang ZQ, Zhang XH, Russell JC, et al. Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR: LA-cp rats. J Nutr. 2006;136:415–420
  47. Sundaram RK, Bhaskar A, Vijayalingam S, et al. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci. 1996;90:255–260
  48. Morrow JD, Minton TA, Badr KF, et al. Evidence that the F2-isoprostane, 8-epi-prostaglandin F2a, is formed in vivo. Biochim Biophys Acta. 1994;1210:244–248
  49. Roberts LJ, Morrow JD. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med. 2000;28:505–513
  50. Moore K. Isoprostane and the liver. Chem Phys Lipids. 2004;128:125–133
  51. Basu S. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity. Biochem Biophys Res Commun. 1999;254:764–767
  52. Pratico D, Tangirala RK, Rader DJ, et al. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in Apo E-deficient mice. Nat Med. 1998;4:1189–1192
  53. Powers SK, Locke M, Demirel HA. Exercise, heat shock proteins, and myocardial protection from I-R injury. Med Sci Sports Exerc. 2001;33:386–392
  54. Burdon RH. Heat shock and the heat shock proteins. Biochem J. 1986;240:313–324
  55. Atalay M, Oksala NK, Laaksonen DE, et al. Exercise training modulates heat shock protein response in diabetic rats. J Appl Physiol. 2004;97:605–611
  56. Gallaher DD, Csallany AS, Shoeman DW, et al. Diabetes increases excretion of urinary malondehyde conjugates in rats. Lipids. 1993;28:663–666
  57. Preuss HG, Grojec PL, Lieberman S, et al. Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats. Clin Nephrol. 1997;47:325–330
  58. Jain SK, Lim G. Chromium chloride inhibits TNF-α and IL-6 secretion in isolated human blood mononuclear cells exposed to high glucose. Horm Metab Res. 2006;38:60–62
  59. Jain SK, Kannan K. Chromium chloride inhibits oxidative stress and TNF-α secretion caused by exposure to high glucose in cultured monocytes. Biochem Biophys Res Commun. 2001;289:687–691
  60. Jain SK, Rains JL, Croad JL. Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-α, IL-6, CRP, glycated hemoglobin, triglycerides and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med. 2007;43:1124–1131
  61. Onderci M, Sahin N, Sahin K, et al. The antioxidant properties of chromium and zinc: in vivo effects on digestibility, lipid peroxidation, antioxidant vitamins and some minerals under a low ambient temperature. Biol Trace Elem Res. 2003;92:139–150
  62. Kalant N, McCormick S. Inhibition by serum components of oxidation and collagen-binding of low-density lipoprotein. Biochim Biophys Acta. 1992;1128:211–219
  63. Pisarenko OI. Mechanisms of myocardial protection by amino acids: facts and hypotheses. Clin Exp Pharmacol Physiol. 1996;23:627–633
  64. Jensen PK, Christiansen JS, Steven K, et al. Renal function in streptozotocin-diabetic rats. Diabetologia. 1981;21:409–414
  65. Dai S, Yuen VG, Orvig C, et al. Prevention of diabetes-induced pathology in STZ-diabetic rats by bis(maltolato)oxovanadium (IV). Pharmacol Commun. 1993;3:311–321
  66. Rhodes MC, Hebert CD, Herbert RA, et al. Absence of toxic effects in F344/N rats and B6C3F1 mice following subchronic administration of chromium picolinate monohydrate. Food Chem Toxicol. 2005;43:21–29
  67. Mozaffari MS, Patel C, Ballas C, et al. Effects of chronic chromium picolinate treatment in uninephrectomized rat. Metabolism. 2005;54:1243–1249

PII: S1051-2276(09)00104-6

doi: 10.1053/j.jrn.2009.04.009

Journal of Renal Nutrition
Volume 20, Issue 2 , Pages 112-120 , March 2010

Article Tools

* Image Usage & Resolution